OncoSil Medical files for US FDA approval for specialist device
OncoSil Medical has hit a key milestone in its plans to commercialise its unique OncoSil device for the treatment of dCCA.
Market Cap $1.707B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.25pm 03/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $1.40 | Day High | $1.41 | Day Low | $1.38 | |||
| Daily Volume | 4535187 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | $1.37 | 10729 | 0 | $1.39 | 7475 | |
Directors & Senior Management
| Mr. Alan Robert Harold Sindel | Independent Non-Executive Chairman |
| Ms. Angela Di Iorio | Chief People Officer |
| Ms. Ann L. Stubbings | Chief Safety, Sus. & Governance Officer, Company Secretary and Group General Counsel |
| Mr. Brian Phillip Lowe | CEO, MD & Director |
| Mr. Claude-Alain Tardy | Independent Non-Executive Director |
| Mr. Emmanuel Ladent | President of Global Glass Business |
| Ms. Jacqueline McArthur | Independent Non-Executive Director |
| Mr. Michael Anthony Fraser | Independent Non-Executive Director |
| Ms. Sarah Myree Hofman | Independent Non-Executive Director |
| Mr. Shaun C. Hughes | Chief Financial Officer |
| Ms. Susannah Jobling Hodgens | Additional Company Secretary |
| Mr. Thomas Joseph Gorman | Independent Non-Executive Director |
Data source: ADVFN
